Bogart Wealth LLC’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27K Buy
24
+16
+200% +$1.97K ﹤0.01% 1325
2026
Q1
$943 Buy
+8
New +$1.12K ﹤0.01% 1464
2025
Q4
– Sell
-4
Closed -$535 – 1670
2025
Q3
$535 Buy
+4
New +$486 ﹤0.01% 1402
2025
Q2
– Sell
-3
Closed -$382 – 1529
2025
Q1
$382 Buy
+3
New +$462 ﹤0.01% 1325
2023
Q2
– Sell
-13
Closed -$2.19K – 1108
2023
Q1
$2.19K Buy
+13
New +$2.32K ﹤0.01% 893

Other funds holding RGEN

Bogart Wealth LLC's RGEN Position: Q2 2026 in Review

Bogart Wealth LLC increased its Repligen (RGEN) stake by 200% in Q2 2026, buying an estimated $1.97K and bringing the position to 24 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Bogart Wealth LLC first reported a position in RGEN in Q1 2023 and has held it in 5 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Bogart Wealth LLC held 24 shares of Repligen worth $3.27K as of Q2 2026.
  • Bogart Wealth LLC bought 16 Repligen shares in Q2 2026, an estimated $1.97K.
  • Repligen made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1325 holding.
  • Bogart Wealth LLC first reported a position in Repligen in Q1 2023 and has held it in 5 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.